NASDAQ:LXRX

Lexicon Pharmaceuticals Stock News

etoro logo Buy LXRX
*Your capital is at risk
$1.85
-0.0400 (-2.12%)
At Close: Jun 03, 2026
Investors need to pay close attention to Lexicon Pharmaceuticals (LXRX) stock based on the movements in the options market lately.
Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q4 2020 Results - Earnings Call Transcript
Conference Call and Webcast at 5:00 pm Eastern Time Conference Call and Webcast at 5:00 pm Eastern Time
Lexicon (LXRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sotagliflozin was rejected by the FDA in 2019 citing diabetic ketoacidosis in type 1 diabetes patients. This time, the company has a new approach and some strong CV benefits data that may change the F
Let us take a look at some drug/biotech stocks that are poised to beat on fourth-quarter earnings.

Should You Buy Lexicon Pharmaceuticals Stock?

06:55am, Saturday, 06'th Feb 2021
Your portfolio could benefit from its group of soon-to-be-commercialized drugs.
With the trading day practically over, the broad markets were sliding into the weekend.
The stock price of Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) increased by 78.21% this past week. This is why it happened.

3 Biotech Stocks That Jumped Last Week

09:59am, Sunday, 17'th Jan 2021
Find out what led to the biotech industry's biggest gains.
A downgrade from an analyst might have something to do with it.
Lexicon (LXRX) announces that data from two late-stage studies on its type II diabetes candidate, sotagliflozin, can support a regulatory approval application.
The FDA delivered a powerful shot of good news to the company.
Lexicon Pharmaceuticals (LXRX) stock is on the rise Thursday after announcing an update from the FDA for its drug sotagliflozin. The post LXRX Stock Alert: Why Lexicon Pharmaceuticals Is Up 100%+ Toda
Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) shares jumped on Thursday morning after the company announced that it received regulatory feedback from the U.S.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE